Business Context and Reporting Period
This Form 8-K was filed by Bausch Health Companies Inc. on January 13, 2026. The filing serves as a current report regarding the company's upcoming participation in the 44th Annual J.P. Morgan Healthcare Conference scheduled for January 14, 2026.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. This document is an announcement of an upcoming event rather than a financial results report.
Material Changes
No material changes to financial results or operations are reported in this filing. The document references a previous news wire release from January 5, 2026, regarding the conference participation.
Guidance, Outlook, and Management Commentary
- Conference Presentation: Management will present strategic and business updates at the J.P. Morgan Healthcare Conference on January 14, 2026, at approximately 3:45 p.m. PT.
- Guidance Reaffirmation: Management expects to reaffirm the full-year 2025 guidance at the higher end of the range previously provided in the third-quarter 2025 financial results press release (dated October 29, 2025).
- Scope of Guidance: The guidance reaffirmation applies to Bausch Health excluding Bausch + Lomb Corporation.
- Forward-Looking Statements: The filing includes standard cautionary notes regarding risks and uncertainties that could cause actual results to differ from forward-looking statements.
Investor Verification Checklist
- Verify the specific numerical range for the full-year 2025 guidance by reviewing the Q3 2025 press release dated October 29, 2025.
- Confirm the distinction between Bausch Health's consolidated results and the results excluding Bausch + Lomb Corporation.
- Access the live audio webcast or replay on the company's Investor Relations website for the detailed strategic updates.
- Review the most recent Form 10-K for a comprehensive list of risks and uncertainties affecting the forward-looking statements.